SUNY Downstate’s STAR Program Receives More than $2 Million in Additional New Funding
Jan 24, 2014
STAR Has a Quarter-century History of Combatting HIV/AIDS in Brooklyn
Brooklyn, NY – SUNY Downstate Health Sciences University’s Special Treatment and Research (STAR) Program has received five new awards totaling more than $2 million. Added to previously announced awards, STAR Program faculty received approximately $5 million in funding awards in 2013. The STAR Program has a quarter-century history of providing innovative HIV primary and specialty care, research, prevention services, and clinical education in Central Brooklyn.
Funding that SUNY Downstate has received for all HIV/AIDS-related clinical and research activities since the beginning of the HIV epidemic totals $152 million.
“Brooklyn continues to be at the center of the AIDS epidemic,” said Jack DeHovitz, MD, MPH, distinguished service professor of medicine and STAR Program director, “but the nature of the epidemic is changing, and these new grants reflect Downstate’s history of developing new means of reaching and treating the people most at risk.”
Expanded Treatment for Substance Abuse
Two awards come from the federal Substance Abuse and Mental Health Services Administration. A $1.56 million award will enable STAR to expand its substance abuse and HIV treatment program for Black and Hispanic/Latina adult women. The three-year project will address behaviors stemming from active substance abuse that may place women at risk for acquiring or transmitting HIV. Led by Dr. DeHovitz, principal investigator of the project, this will include efforts to identify lesbian, bisexual, and previously incarcerated women who have substance abuse and/or mental health disorders. The program will use interventions such as Motivational Interviewing (which seeks to elicit changes in client behavior), Seeking Safety (a type of cognitive/behavioral group therapy used to treat individuals with post-traumatic stress disorder or substance abuse), and acupuncture, which can be used as a complementary therapy for substance abuse.
A $116,000 project, with Dr. DeHovitz as principal investigator, will develop and implement a social media initiative to reduce substance abuse and HIV transmission, focusing on young African-American and Afro-Caribbean men who have sex with men, as well as focusing on male-to-female transgender women. The project will address chronic health disparities rooted in sexual orientation and gender identity discrimination using text-messaging and online surveys. Peer mentors will complement the use of new media.
Reducing Secondary HIV Transmission
The New York City Department of Health and Mental Hygiene has awarded Downstate $160,000 as part of the City’s multi-site Prevention with Positives Project. This program aims to reduce secondary HIV transmission by creating new means for healthcare providers to reduce risky behaviors among HIV-positive persons and determine which of the new techniques are the most effective. The effort implemented at the STAR Health Center will involve a self-administered risk behavior screening, followed by provider-delivered and group-based risk reduction counseling sessions. In addition, the project will customize existing electronic health records to prompt and monitor risk behavior screenings, provider-delivered counseling, and any necessary referrals and follow-up. Jameela Yusuff, MD, MPH, assistant professor of medicine and STAR Program medical director, is principal investigator of this project.
Additional Ryan White Funding
The HIV/AIDS Bureau of the federal Health Resources and Services Administration (HRSA) has given Downstate a Ryan White Part C Capacity Development Award in the amount of $84,000, with Dr. DeHovitz as principal investigator. The award will fund the delivery of a novel screening procedure for people living with HIV or AIDS in order to reduce the incidence of anal cancer. The funds will be used to purchase high-resolution anoscopy (HRA) equipment, to train and supervise HIV clinicians in its use, and to perform HRA. The implementation of this relatively new technology will enable identification and treatment of this disease far earlier, analogous to the implementation of Pap smears to prevent cervical cancer.
HRSA’s HIV/AIDS Bureau has also given Downstate a Ryan White Part C Supplemental Award of $525,000 over a two-year period. The award will allow the STAR Program, under the direction of Dr. DeHovitz, to further the recruitment of culturally competent staff members and enhance primary care services of the STAR Health Center through the implementation of a home visiting program.
Previously announced STAR Program-related funding for 2013 includes a $1,197,766 award from the New York State Department of Health’s Empire Clinical Research Investigator Program (ECRIP). This award will enable Downstate to study the accelerated aging phenomenon found in successfully treated HIV patients, which includes an unusual variant of arteriosclerotic disease. The principal investigator is Deborah R. Gustafson, PhD, professor of neurology. The team of collaborating investigators includes Alison Baird, MD, PhD, professor of neurology and physiology and pharmacology; Howard Crystal, MD, professor of neurology; Jason Lazar, MD, MPH, professor of medicine; Steven Levine, MD, professor of neurology and emergency medicine; and Dr. DeHovitz.
Also as previously announced, HRSA’s AIDS Education and Training Center gave the STAR Program, led by Dr. DeHovitz, a $1.5 million award to educate and train physician assistants in HIV care, in collaboration with the Physician Assistant Program in Downstate’s School of Health Professions. Dawn Morton-Rias, EdD, PA-C, is dean of the School of Health Professions. Felix Nwamaghinna, MSB, RPA-C, is chair of the Physician Assistant Program.
###
About SUNY Downstate Health Sciences University
Downstate Health Sciences University in Brooklyn is one of four academic health centers (AMCs) in The State University of New York (SUNY) 64-campus system and the only SUNY AMC in New York City dedicated to health education, research, and patient care for the borough’s 2.7 million residents. Its flagship hospital, University Hospital at Downstate (UHD), is a teaching hospital and benefits from the expertise of Downstate’s exceptional medical school and world-class academic center research facilities. With a staff of over 800 physicians representing 53 specialties and subspecialties, Downstate offers comprehensive healthcare services to the community.
UHD provides high-risk neonatal and infant services, pediatric nephrology, and dialysis for kidney diseases and is the only kidney transplantation program in Brooklyn. Beyond its clinical expertise, Downstate houses a range of esteemed educational institutions, including its College of Medicine, College of Nursing, School of Health Professions, School of Graduate Studies, and School of Public Health. Downstate fosters innovation through its multifaceted biotechnology initiative, the Biotechnology Incubator and BioBAT, which support early-stage and more mature biotech companies.